Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$140,010,830
-$37,645,086 QoQ
Shares Held
313,546
-20.0% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Harding Loevner LP holds $226,714,684 across 2 Biotechnology names. VRTX ranks #1 (61.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
313,546 | $140,010,830 | |
| 2 | GMAB |
Genmab A/S
|
3,231,601 | $86,703,854 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $140,010,830 | 313,546 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $177,655,916 | 391,865 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $178,583,140 | 455,988 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $316,809,217 | 711,611 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $338,626,892 | 698,459 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $331,674,592 | 823,627 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $536,062,835 | 1,152,625 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $555,155,717 | 1,184,408 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $511,242,114 | 1,223,038 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $537,594,867 | 1,321,229 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $468,319,192 | 1,346,751 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $541,332,595 | 1,538,270 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $575,514,423 | 1,826,624 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $531,505,654 | 1,840,521 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $474,792,614 | 1,639,817 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $488,536,786 | 1,733,691 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $461,727,957 | 1,769,276 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $413,258,871 | 1,881,871 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $346,654,973 | 1,911,103 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $403,074,097 | 1,999,078 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $426,145,995 | 1,983,089 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $482,865,072 | 2,043,095 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $544,387,216 | 2,000,541 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $586,939,177 | 2,021,767 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $487,148,848 | 2,047,274 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||